Available Content Prous Science Drug Data Report tracks the progress of over 70,000 bioactive compounds from the patent stage through to marketing. PRDR from Prous Science Publishers links chemical and pharmacological information for a compound, including the chemical name, with patent and biomedical literature references. About 10,000 new compounds are added each year. The full information for one drug is maintained in one document. Patent information includes patent family, priorities, inventors and applicant.
Special emphasis is placed on obtaining information from Japanese language literature.
Due to the compound's enhanced delivery of acyclovir and its favorable pharmacokinetic profile, it has been moved to phase II studies. Entry number 149658 Preferred. Preferred compound 149658. Literature and patent references are associated with preferred compounds, which are selected by Prous experts, according to pharmacological activity profile. Secondary compounds have the basic compound details, and a PC paragraph giving the Entry number of the preferred compound where the patent and literature references can be found.